Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock might soar as investors bet on the company’s cutting-edge technology through its development stages — and the stock could continue to gain after that company moves into the product commercialization stage.
And to truly maximize your potential for a biotech win, it’s a good idea to get in on players during their early stages of growth — and at a reasonable price. This does involve some risk because the product development process isn’t always smooth and doesn’t always result in victory. To minimize risk, though, consider players with a full pipeline of potential products and the resources to support their development — and get ready to hold on for the long term.
With this in mind, let’s check out two no-brainer biotech stocks to buy right now.
This post originally appeared at The Motley Fool.